Can antibodies alone establish active infection or catabolic illness?

Serologic testing is most informative when it answers a focused clinical question. In an 84-year-old man, an isolated positive antibody result should not be used to attribute nonspecific symptoms, weight loss, or functional decline to ongoing infection without a compatible syndrome and corroborating evidence.

Interpretation of serology

• Borrelia IgM and IgG antibodies can remain detectable for years to decades after eradicated infection. A positive result therefore cannot distinguish remote exposure from active disease.
• Diagnostic value depends strongly on pretest probability: compatible symptoms, exposure history, geography, and timing of illness are essential. In a cited low-incidence setting among people without recent travel to an endemic area, the positive predictive value of Lyme testing was only 10%.
• Cross-reactivity, autoimmune conditions, assay variation, and—in Bartonella testing—variation by isotype, titer, laboratory method, and exposure context can further make isolated antibody positivity nondiagnostic.
• Confirmatory testing must be syndrome-specific. PCR may support diagnosis in selected settings, such as synovial fluid in suspected Lyme arthritis, but blood and cerebrospinal-fluid PCR have limited sensitivity; a negative result in an unsuitable specimen does not reliably exclude disease.

Catabolic illness and mechanisms

• Active infection can produce cytokine-mediated systemic inflammation. TNF-α, IL-1β, and IL-6 can promote muscle-protein breakdown and impair anabolic signaling, providing a biologically plausible route from confirmed infection to weight loss and muscle loss.
• This mechanism does not allow antibody positivity alone to establish an inflammatory or catabolic state. Cachexia or related catabolic illness requires documented involuntary weight loss plus assessment of muscle mass, function, symptoms, inflammatory context, and alternative causes.
• CRP is nonspecific, and albumin during inflammation is not a stand-alone nutritional marker.

Bottom line

• Positive serology without a compatible clinical syndrome and appropriately selected corroboration does not establish active infection or an infection-driven catabolic illness; it may instead reflect prior cleared infection or a non-specific test result.